Universal Ibogaine Inc. (TSXV:IBO)

Universal Ibogaine Revenue

Universal Ibogaine had revenue of 700.92K CAD in the quarter ending April 30, 2025, with 30.61% growth. This brings the company's revenue in the last twelve months to 2.06M, down -11.68% year-over-year. In the fiscal year ending July 31, 2024, Universal Ibogaine had annual revenue of 2.33M with 126.32% growth.

• Revenue (ttm): 2.06M
• Revenue Growth: -11.68%
• P/S Ratio: 0.76
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.56M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jul 31, 2024	2.33M	1.30M	126.32%
Jul 31, 2023	1.03M	-40.82K	-3.81%
Jul 31, 2022	1.07M	-	-
Jul 31, 2021	-	-	-
Jul 31, 2020	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 9, 2026

Data Sources Report a data error